Alkermes (ALKS) Earnings Date & Reports

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALKS is expected to report earnings to fall 97.05% to -1 cents per share on July 29

Q2'26

Est.

$-0.01

Q1'26

Beat

by $0.14

Q4'25

Missed

by $0.12

Q3'25

Beat

by $0.11

Q2'25

Beat

by $0.16

The last earnings report on May 05 showed earnings per share of -40 cents, beating the estimate of -54 cents. With 1.52M shares outstanding, the current market capitalization sits at 7.38B.

View a ticker or compare two or three

Compare

Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)

Annualized Return+21%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ALKS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement